2025 International Congress Archives - Page 58 of 181

Dopamine Responsive ATP1A3 Dystonia Parkinsonism A Case Report

J. Liu, T. Liu, F. Gao (Honolulu, USA)
Dopamine Transporter Imaging as a Predictor of Functional Outcomes in Parkinson’s Disease

K. Niemi, V. Kaasinen, J. Joutsa (Turku, Finland)
Dopamine-Responsive Post-Anoxic Parkinsonism

T. Liu, J. Ahlskog, J. Bower, O. Kantarci, R. Savica (Rochester, USA)
Dopaminergic and Synaptic Alterations in SWEDD: Insights from [¹⁸F] FE-PE2I and [¹¹C] UCB-J PET Imaging

F. Ebrahimian Sadabad, T. Volpi, P. Honhar, L. Colon, S. Tinaz, M. Naganawa, M. Dias, G. Angarita, R. Comley, R. Carson, S. Finnema, D. Matuskey (Tallahassee, USA)
Dopaminometer: A Smartphone-Based Application to Predict Striatal Dopaminergic Deficit in Prodromal and Manifest Parkinson’s disease

K. Gunter, K. Groenewald, J. Klein, T. Aubourg, J. Razzaque, C. Lo, P. Ratti, L. van Hillegondsberg, J. Welch, A. Nastasa, K. Bradley, D. Mcgowan, B. Orso, P. Mattioli, M. Pardini, S. Raffa, F. Massa, D. Arnaldi, S. Arora, M. Hu (Oxford, United Kingdom)
Dosage Optimization and Treatment Outcomes of Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion in Parkinson’s Disease: a single center study

K. Kakuda, Y. Kimura, K. Ikenaka, H. Mochizuki (Suita, Japan)
Dose Optimization of Foslevodopa/Foscarbidopa: Post Hoc Analysis of Study Completers

J. Aldred, M. Bouchard, D. Kern, P. Mir, L. Bergmann, R. Gupta, M. O'Meara, J. Samuelsson, B. Bergmans (Spokane, USA)
Down-titration of levodopa complicated by catatonia

D. Newbold, . (New York, USA)
DPPX Autoimmune Encephalitis Presenting with Chorea

T. Le, S. Pradeep (Houston, USA)
Drawing Impairments Linked to Altered Cortico-Subcortical Interactions in Writer’s Cramp

M. Muthuraman, G. Deuschl, C. Ip, J. Volkmann, M. Bange (Augsburg, Germany)